The study authors said they aimed to develop a robust and safe Crispr-Cas regimen, striving for an inclusive HIV cure for all that can inactivate diverse HIV strains across various cellular contexts.
Trending
- Kogi launches integrated MNCH, HPV, NTDs campaign
- Rivers NMA dismisses claims of magical genital theft
- Kwara distributes over 14,423 MMS during MNCH week
- UniCal faculty of agriculture launches commercial palm oil sales
- Kano secures 150 trucks of fertilizer for farmers
- Menstrual hygiene: NEHI unveils ‘Bleed with Pride’ handbook in Bauchi
- CISLAC raises alarm over Sowore’s alleged assault, Kaduna lynching
- CBN orders banks to freeze accounts linked to terror financing suspects, BDCs
